Research Article
Glycemic Characteristics and Clinical Outcomes in Patients with COVID-19 Admitted to Referral Shahid Sayad Shirazi Hospital in Gorgan, North of Iran
Table 1
The clinical profile and outcomes in COVID-19 patients.
| | Factors | Frequency (%) |
| | Symptoms | | Shortness of breath | 88 (21.2) | | Cough | 121 (29.1) | | Diarrhea and vomiting | 21 (5) | | Weakness and lethargy | 44 (10.6) | | Fever | 35 (8.4) | | Shortness of breath and cough | 107 (25.7) | | Previous disease history | | Heart failure | 16 (3.8) | | Respiratory failure | 1 (0.2) | | Kidney failure | 5 (1.2) | | Pulmonary involvement | | <25% | 17 (4.1) | | 25–50% | 39 (9.3) | | 50–75% | 31 (7.4) | | ≥75% | 5 (1.2) | | Severe disease | | ICU admission | 14 (3.3) | | Need a ventilator | 15 (3.6) | | Loss of consciousness | 5 (1.2) | | SpO2 drops to less than 90% | 7 (1.7) | | Corticosteroid administration | | Dexamethasone | 399 (95.5) | | Methylprednisolone | 17 (4.1) | | Anti-COVID-19 | | Remdesivir | 395 (94.5) | | Actemra | 18 (4.3) | | Other | 3 (0.7) | | Outcomes | | Discharge without complications | 338 (80.8) | | Discharge with complications | 50 (12) | | Death | 30 (7.2) |
| | Quantitative variables | Mean ± SD (range) |
| | SBP(mmHg) | 121.6 ± 16.4 (43–195) | | DBP (mmHg) | 75.1 ± 11.6 (10–185) | | PR (/minute) | 90.5 ± 16.1 (49–200) | | RR (/minute) | 19 ± 3.8 (10–40) | | Temperature (C°) | 37.3 ± 1.5 (18–40) | | SpO2 at time of admission (%) | 92 ± 6.3 (37–100) | | SpO2 at discharge (%) | 93.5 ± 7.5 (40–100) | | Serum creatinine (mg/dl) | 1.22 ± 0.42 (0.4–3.8) | | eGFR (mL/min/1.73 m2) | 64.8 ± 20.3 (14.4–136.3) |
|
|
BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; PR, pulse rate; RR, respiratory rate; SpO2, blood oxygen saturation level; eGFR, estimated glomerular filtration rate.
|
